Login / Signup

Glucocorticoid discontinuation in pediatric-onset systemic lupus erythematosus: a single-center experience.

Kentaro NishiMasao OguraSho IshiwaToru KanamoriMika OkutsuShunsuke YokotaTaishi NadaMai SatoKoichi KameiKenji IshikuraShuichi Ito
Published in: Pediatric nephrology (Berlin, Germany) (2022)
Despite the small sample size, these results support glucocorticoid discontinuation as a therapeutic target in pediatric SLE.
Keyphrases
  • systemic lupus erythematosus
  • disease activity
  • young adults
  • childhood cancer